Mukka Proteins Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Mukka Proteins Limited generated cash of -$1,504,080,000, which is less than the previous year. Cash used in financing activities reached the amount of $2,658,920,000 last year. Net change in cash is therefore $678,900,000.
Cash Flow
| 2020 | -297.89M | -289.74M | 595.04M |
|---|---|---|---|
| 2023 | -655.31M | -53.83M | 859.26M |
| 2024 | -1.50B | -475.94M | 2.65B |
MUKKA.NS Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2019 | |
|---|---|---|---|
Cash at beginning of period | 265.48M | 115.35M | 6.91M |
Operating activities | |||
Net income | 700.52M | 440.75M | 131.75M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 123.38M | 118.51M | 46.91M |
Stock-based compensation expense | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | -624.77M | -999.07M | -393.27M |
Inventories | -1.93B | -649.04M | -250.55M |
Accounts payable | 54.02M | 353.17M | 217.34M |
Cash generated by operating activities | -1.50B | -655.31M | -297.89M |
Investing activities | |||
Purchases Of Investments | 0 | -9.25M | 0 |
Investments In Property Plant And Equipment | -176.19M | -82.15M | -363.95M |
Acquisitions Net | 31.06M | 2.06M | 0 |
Cash generated by investing activities | -475.94M | -53.83M | -289.74M |
Financing activities | |||
Common Stock Issued | 1.80B | 0 | 6.99M |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | 1.07B | 869.64M | 588.04M |
Cash used in financing activities | 2.65B | 859.26M | 595.04M |
Net Change In Cash | 678.9M | 150.13M | 8M |
Cash at end of period | 944.38M | 265.48M | 14.91M |
| Data source | Data source | Data source |